The move is expected to cause a “near-term stock out of Bicillin L-A,” Pfizer said in its statement, with the drugmaker now ...

Tevogen ('Tevogen Bio Holdings Inc.” or 'Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. The facility, formerly ...

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

U.S. Bancorp notched a rise in earnings for the latest quarter as it benefited from a lower loan-loss provision and growth in fee income. The healthcare-products maker trimmed and narrowed its ...

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

The industry has long boasted healthy and steady growth rates. Critically, Zoetis also boasts high and improving levels of profitability.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...

Over the last nine months, four senators led by Sen. Dick Durbin (D-Ill.) have conducted an inquiry into the growing partnerships between direct-to-consumer telehealth companies and pharmaceutical ...

David Katz, CIO at Matrix Asset Advisors, tells 'Worldwide Exchange' the market is jittery, tech looks overbought, and Pfizer ...

US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, available directly ...

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...